Coronavirus Vaccine 2020: Glenmark launched Favipiravir tablets for treatment of COVID19
Current updates Health

Coronavirus vaccine 2020: No more cases after Glenmark Launched Favipiravir tablets?

Education and Health are the two main important keys to categorized as a Developed nation or Developing Nation. As you know, the world is Suffering from COVID19 Pandemic. Do you ever wonder what will happen to this world if Coronavirus couldn’t Vanish? Could be any invention for coronavirus vaccine 2020.

Recently, Glenmark Launched a Favipiravir tablet under the brand “Fabi-Flu”. Could this the end of Coronavirus?

May be You are thinking that ” That’s a Materstroke, Now Coronavirus vaccine 2020 has been launched and COVID19 will be only for few more days”. Do you think that 2020 will let this world “free” too soon.

Is Coronavirus Vaccine 2020 fully Ready?

Heath is the Primary key for any country to develop the nation. We can easily defined by Health whether a specific country is developed or Developing Nation.

Now main question arises that whether the Coronavirus Vaccine 2020 is fully ready or not?

Glenmark Pharmaceuticals Limited has announced that they have launched a Favipiravir tablet for the treatment of COVID19 Pandemic. Favipiravir has Launched under the brand name of Fabi-Flu.

Now the Next genuine question arises in your mind that what is the Price of Favipiravir Tablets?

You Must Read: International Yoga Day 2020 : Treatment of Coronavirus Disease 2019

International Yoga Day 2020

Price of Favipiravir Tablets for the treatment of COVID19 Pandemic

The Price of Favipiravir Tablets for the treatment of COVID19 is Rs 3,500. I know that it’s not reliable for those who are below poverty line.

Price at Rs 103 tablet, the Perception-based drug will be available as a 200 mg tablet at an MRP of Rs 3,500 for a strip of 24 tablets.

Coronavirus vaccine 2020: Glenmark gives the Permission for the Production of Favipiravir tablets
Coronavirus vaccine 2020: Glenmark gives the Permission for the Production of Favipiravir tablets
source: India TV

Advantage and Disadvantage of Favipiravir tablets

As Aforesaid glenmark launched favipiravir tablets for the treatment of COVID19 Pandemic. The Headquarter of Favipiravir Pharmaceuticals Limited is at Mumbai, India.

What is the Advantage and Disadvantage of Favipiravir Tablets?

Advantage of Favipiravir Tablets

Coronavius Disease has spread all over the world. Many of Lives are Deceased due to this Pandemic .

Total Confirmed Cases 8.99M
Recovered Cases 4.46M
Deaths 469K
Latest Update of Coronavirus Pandemic

Above Data has an feeling of that “slowly and Steady this world would be Vanished”

  • After Glenmark Launched favipiravir tablets the new hope of life has arisen.
  • Favipiravir tablets will be given to those who are mild to moderately affected by COVID19 Pandemic.
  • Favipiravir Tablets are for who are between 18 to 75 age. Approximately 95% of coronavirus Patients are at this age.
  • It is oral Antiviral Drug so it can be intake by an individual at Home only.
  • It doesn’t require hospital infrastructures for treatment of COVID19.

Disadvantage of Favipiravir Tablets

Yes you are right Predicted the Disadvantage of Favipiravir Tablets. The price is too much that Middle class Coronavirus Patients will not be able to Purchase the Favipiravir Tablets.

Price at Rs 103 tablet, the Perception-based drug will be available as a 200 mg tablet at an MRP of Rs 3,500 for a strip of 24 tablets.

This Tablet can’t be intake by normal Person. This Tablet will be given to COVID19 Patients after doctor Perceptions.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *